Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Cancer
2		Additional conditions recognized in this trial
			Lymphoma, Large-Cell, Immunoblastic
			Lymphoma, Non-Hodgkin
			Neutropenia
3		More general conditions related to this trial
			Agranulocytosis
			Hematologic Diseases
			Immune System Diseases
			Immunoproliferative Disorders
			Leukocyte Disorders
			Leukopenia
			Lymphatic Diseases
			Lymphoma
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			caspofungin acetate
			liposomal amphotericin B
5		Additional drug interventions recognized in this trial
			Abelcet
			AmBisome
			Amphotericin B
			Caspofungin
6		More general drug interventions related to this trial
			Amebicides
			Anti-Bacterial Agents
			Anti-Infective Agents
			Antibiotics, Antifungal
			Antifungal Agents
			Antiparasitic Agents
			Antiprotozoal Agents
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Memorial Sloan-Kettering Cancer Center
			National Cancer Institute (NCI)